Myasthenia Gravis Trial, Recruiting NCT06491238 Sponsor: HealthPartners Institute Condition: Myasthenia Gravis
Back to Myasthenia Gravis

Myasthenia Gravis Trial, Recruiting

NCT06491238
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are able to understand and sign a consent form agreeing to take part in the study
  • You are between 18 and 80 years old
  • You have been diagnosed with generalized Myasthenia Gravis (MG), meaning MG that affects muscles across your body
  • You have been on the same MG medications without changes for at least the last 3 months

Who may not be able to join:

  • You do not speak English
  • You have exercised regularly in the month before joining the study, or you plan to do outside exercise during the study
  • You have significant memory or thinking difficulties that would make it hard to take part in the study
  • You have a history of heart failure, chronic lung disease, chest pain (angina), or any other condition that causes unusual breathlessness during physical activity
  • You have a history of serious neurological conditions, psychiatric conditions, or substance use disorders that could affect your ability to take part
  • You are currently pregnant or planning to become pregnant during the study
  • You have any other health condition that the study team believes would prevent you from safely doing exercise during the study (confirm with trial site)
  • You are currently taking part in, or have taken part in, another research study involving a treatment or intervention within the last 3 months
  • You are not willing to take part in all activities required by the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 651-495-6363

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
HealthPartners Institute
Registry
ClinicalTrials.gov
Start date
16 September 2024
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of light and moderate intensity exercise; Acceptability of light and moderate intensity exercise; Tolerability of light and moderate intensity exercise

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov